Puissance Life Science Opportunities Fund VI

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 91% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Puissance Life Science Opportunities Fund VI's trades of Bellerophon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
9.46
Quantity 560,000
Value US$5,297,600
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-07 2023-06-07
PrS Proposed sale
92,783
165.63
US$502,266 		92,783 165.63 US$502,266
2023-06-07 2023-06-07
S Sale
46,695 -36.9%
124.28
US$4,420,056 		46,695 -36.9% 124.28 US$4,420,056
2023-05-19 2023-05-18
S Sale
24,681 +1.7%
422.85
US$3,842,145 		24,681 +1.7% 422.85 US$3,842,145
2023-05-18 2023-05-18
PrS Proposed sale
560,000
9.46
US$5,297,600 		560,000 9.46 US$5,297,600